Company: ARVN
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001655759-25-000075
Chunk: 55

Company: ARVINAS, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 55
---
 in line with our 30-day stock price and Black Scholes percentage, in February 2024, our compensation committee approved annual equity incentive awards for our named executive officers. The number of Options awarded and RSUs to each named executive officer was based on the 30-day average stock price of our common stock on the Nasdaq Global Select Mar ket as of January 5, 2024, which was of $37.89, and Black Scholes percentage of 67.6% of face value. The exercise price for each of these Options was $47.00, w hich was equal to the closing price of our common stock on the Nasdaq Global Select Market on the date of grant.

The equity incentive awards granted to our named executive officers who were employed at the time of grant, as well as promotional and inducement awards, to named executive officers promoted or joining the company following the annual grants, are set forth in the table below. Sean Cassidy was not granted any equity in 2024 as he stepped down as our Chief

<div align='center'>39</div>

Financial Officer, Treasurer and principal financial officer to pursue another professional opportunity effective February 29, 2024.

Annual Grants

| Named Executive Officer  |     | Stock Options 
 (#)           |         |     | RSUs 
 (#)  |         |
| John Houston, Ph.D. (1)  |     |               | 184,200 |     |      | 124,450 |
| Randy Teel, Ph.D. (1)    |     |               |  34,161 |     |      |  23,093 |
| Angela Cacace, Ph.D. (1) |     |               |  23,425 |     |      |  15,835 |
| Ian Taylor, Ph.D. (1)    |     |               |  58,100 |     |      |  39,250 |

#### Promotional and Inducement Grants
| Named Executive Officer         |     | Stock Options 
 (#)           |        |     | RSUs 
 (#)  |        |
| Andrew Saik (2)                 |     |               | 94,418 |     |      | 61,409 |
| Randy Teel, Ph.D. (3)           |     |               | 19,675 |     |      | 13,300 |
| Noah Berkowitz, M.D., Ph.D. (4)